Janssen Launches Patent Suit Over Prostate Cancer Drug
A Johnson & Johnson unit has launched a patent suit against Aurobindo Pharma in New Jersey federal court seeking to block a generic version of prostate cancer drug Erleada....To view the full article, register now.
Already a subscriber? Click here to view full article